|
|
|
The future of clinical trials: Join STAT’s webinar from 1 to 2 p.m. ET Tuesday, Jan. 22, to delve into new approaches, examine case studies, and better understand how the drug industry, with encouragement from the FDA, is working to streamline the process of figuring out whether a treatment actually works. Register here.
|
|
|
KRISTOFFER TRIPPLAAR/AP IMAGES
Good afternoon.
Larry Merlo, chief executive of CVS (above), has big ideas for how his company will transform health care. Anything Amazon does, CVS will do better, he said, including, maybe, delivery by drone.
One of the many proposals the Trump administration is kicking around in order to lower drug costs would shift coverage of some medicines from Medicare Part B to Part D. A new analysis, however, cautions that while government spending might be reduced, the proposal may also increase out-of-pocket costs for some beneficiaries.
After being rebuffed by a federal appeals court last summer, Allergan and the St. Regis Mohawk Tribe have asked the U.S. Supreme Court to decide a vexing question that was at the heart of a controversial maneuver to protect a best-selling eye medicine.
AmerisourceBergen, one of the nation’s largest pharmaceutical wholesalers, is eliminating 225 jobs — roughly 15 percent of the entire workforce — at Pharmedium Services, its troubled compounding unit that has concerned regulators and rattled investors.
Opinion: Life sciences companies competing for talent in 2019 will need to be more nimble, creative, and attentive to attract the best candidates.
Don’t miss
We’ll be back tomorrow with more great stories. |
|
|
|
